These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30610540)

  • 1. The Cerebellum, THC, and Cannabis Addiction: Findings from Animal and Human Studies.
    Moreno-Rius J
    Cerebellum; 2019 Jun; 18(3):593-604. PubMed ID: 30610540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.
    Kesner AJ; Lovinger DM
    J Neurochem; 2021 Jun; 157(5):1674-1696. PubMed ID: 33891706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical basis of cannabis addiction.
    Maldonado R; Berrendero F; Ozaita A; Robledo P
    Neuroscience; 2011 May; 181():1-17. PubMed ID: 21334423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar alterations in cannabis users: A systematic review.
    Blithikioti C; Miquel L; Batalla A; Rubio B; Maffei G; Herreros I; Gual A; Verschure P; Balcells-Oliveró M
    Addict Biol; 2019 Nov; 24(6):1121-1137. PubMed ID: 30811097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction.
    Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T
    Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis abuse and addiction: a contemporary literature review.
    Iyalomhe GB
    Niger J Med; 2009; 18(2):128-33. PubMed ID: 19630315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropsychopharmacology of cannabis: A review of human imaging studies.
    Bloomfield MAP; Hindocha C; Green SF; Wall MB; Lees R; Petrilli K; Costello H; Ogunbiyi MO; Bossong MG; Freeman TP
    Pharmacol Ther; 2019 Mar; 195():132-161. PubMed ID: 30347211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addiction and the pharmacology of cannabis: implications for medicine and the law.
    Lader M
    Med Sci Law; 2009 Jan; 49(1):1-17. PubMed ID: 19306615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users.
    Filbey FM; Dunlop J; Ketcherside A; Baine J; Rhinehardt T; Kuhn B; DeWitt S; Alvi T
    Hum Brain Mapp; 2016 Oct; 37(10):3431-43. PubMed ID: 27168331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
    Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
    Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.
    Panlilio LV; Justinova Z
    Neuropsychopharmacology; 2018 Jan; 43(1):116-141. PubMed ID: 28845848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Problem with the Current High Potency THC Marijuana from the Perspective of an Addiction Psychiatrist.
    Stuyt E
    Mo Med; 2018; 115(6):482-486. PubMed ID: 30643324
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220).
    Blum K; Morgan J; Cadet JL; Baron D; Carney PR; Khalsa J; Badgaiyan RD; Gold MS
    Neurology (ECronicon); 2021 Apr; 13(4):86-92. PubMed ID: 34085060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users.
    Lorenzetti V; Solowij N; Yücel M
    Biol Psychiatry; 2016 Apr; 79(7):e17-31. PubMed ID: 26858212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana dependence: not just smoke and mirrors.
    Ramesh D; Schlosburg JE; Wiebelhaus JM; Lichtman AH
    ILAR J; 2011; 52(3):295-308. PubMed ID: 23382144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis Addiction and the Brain: a Review.
    Zehra A; Burns J; Liu CK; Manza P; Wiers CE; Volkow ND; Wang GJ
    J Neuroimmune Pharmacol; 2018 Dec; 13(4):438-452. PubMed ID: 29556883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vistas on cannabis use disorder.
    Melis M; Frau R; Kalivas PW; Spencer S; Chioma V; Zamberletti E; Rubino T; Parolaro D
    Neuropharmacology; 2017 Sep; 124():62-72. PubMed ID: 28373077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.